SUNRISE, FL--(Marketwire - March 14, 2013) - OrthoSensor™, Inc., the leader in intelligent orthopedics, today announced the Company will present at the Canaccord Genuity Musculoskeletal Conference at the Westin Michigan Avenue Hotel in Chicago, IL.
"OrthoSensor is pioneering the category of intelligent orthopedics to address the huge unmet need of joint implant failure," said Jay Pierce, CEO of OrthoSensor. "The cost to the U.S. healthcare system for hospital charges associated with knee replacement revision procedures is expected to approach $9B in 2015. OrthoSensor's technology drives solutions for all the stakeholders in orthopedics: surgeons, hospitals, payors and patients. The first of our intraoperative surgical systems has been adopted by dozens of orthopedic centers of excellence since we launched last year. Throughout 2013, we will continue to seize the market opportunity with the anticipated introduction of additional intraoperative devices and registry solutions, while furthering the development and commercialization plans for our intelligent implants."
Mr. Pierce will present an overview of the Company on Tuesday, March 19, 2013 at 3:20 p.m. CT (4:20 p.m. ET). To access a webcast replay of the Canaccord Genuity Musculoskeletal Conference presentation, visit http://www.orthosensor.com/about-us/news/orthosensor-events.
About OrthoSensor, Inc.
OrthoSensor, Inc. (www.orthosensor.com) is an innovative medical device company developing and commercializing intelligent orthopedic devices that provide real-time data to surgeons and hospitals during and after surgery. OrthoSensor's intelligent orthopedic devices utilize advanced sensor and wireless communication technology with the goal of improving healthcare outcomes and reducing the cost of treating musculoskeletal disease. The company's intelligent orthopedic instrumentation and implants are designed to enhance surgical implantation, as well as enable remote monitoring of implant function and overall musculoskeletal health.